Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
July 6, 2010
Patent Application Number
11920711
Date Filed
May 26, 2006
Patent Primary Examiner
Patent abstract
IL-10 sequence variants are disclosed that retain the therapeutically desirable anti-inflammatory properties of wild-type IL-10 but do not retain the hemoatopoeitic cell regulatory and cell proliferative activities. The mutant IL-10 polypeptides of the invention are used in methods of treating diseases involving inflammatory response, including neuropathic pain and other neurological disorders.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
